ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global mRNA Vaccines & Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-34F14766
Home | Market Reports | Science| Biological Sciences
Global mRNA Vaccines Therapeutics Market Research Report 2023
BUY CHAPTERS

Global mRNA Vaccines & Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-34F14766
Report
June 2025
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology

mRNA Vaccines & Therapeutics Market Size

In 2024, the global market size of mRNA Vaccines & Therapeutics was estimated to be worth US$ 3403 million and is forecast to reach approximately US$ 1203 million by 2031 with a CAGR of -14.0% during the forecast period 2025-2031.

mRNA Vaccines & Therapeutics Market

mRNA Vaccines & Therapeutics Market

mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of mRNA Vaccines & Therapeutics Market Report

Report Metric Details
Report Name mRNA Vaccines & Therapeutics Market
Forecasted market size in 2031 approximately US$ 1203 million
Forecasted years 2025 - 2031
Segment by Type
  • Infectious Disease Vaccines
  • Cancer Vaccines
Segment by Application
  • Infectious Disease
  • Cancer
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of mRNA Vaccines & Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccines & Therapeutics sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the mRNA Vaccines & Therapeutics Market size in 2031?

Ans: The mRNA Vaccines & Therapeutics Market size in 2031 will be approximately US$ 1203 million.

What is the market share of major companies in mRNA Vaccines & Therapeutics Market?

Ans: The top 3 companies hold a share about 65%.

What is the mRNA Vaccines & Therapeutics Market share by region?

Ans: Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.

Who are the main players in the mRNA Vaccines & Therapeutics Market report?

Ans: The main players in the mRNA Vaccines & Therapeutics Market are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology

What are the Application segmentation covered in the mRNA Vaccines & Therapeutics Market report?

Ans: The Applications covered in the mRNA Vaccines & Therapeutics Market report are Infectious Disease, Cancer

What are the Type segmentation covered in the mRNA Vaccines & Therapeutics Market report?

Ans: The Types covered in the mRNA Vaccines & Therapeutics Market report are Infectious Disease Vaccines, Cancer Vaccines

1 Study Coverage
1.1 mRNA Vaccines & Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Infectious Disease Vaccines
1.2.3 Cancer Vaccines
1.3 Market by Application
1.3.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Infectious Disease
1.3.3 Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global mRNA Vaccines & Therapeutics Market Size Estimates and Forecasts
2.1.1 Global mRNA Vaccines & Therapeutics Revenue 2020-2031
2.1.2 Global mRNA Vaccines & Therapeutics Sales 2020-2031
2.2 mRNA Vaccines & Therapeutics Market Size by Region: 2024 Versus 2031
2.3 mRNA Vaccines & Therapeutics Sales by Region (2020-2031)
2.3.1 Global mRNA Vaccines & Therapeutics Sales by Region: 2020-2025
2.3.2 Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2026-2031)
2.3.3 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2031)
2.4 mRNA Vaccines & Therapeutics Market Estimates and Projections by Region (2026-2031)
2.4.1 Global mRNA Vaccines & Therapeutics Revenue by Region: 2020-2025
2.4.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2026-2031)
2.4.3 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2020-2031)
3.1.1.1 Global mRNA Vaccines & Therapeutics Sales Volume by Type (2020-2031)
3.1.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2031)
3.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
3.1.2.1 Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2031)
3.1.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2020-2031)
3.1.3 mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global mRNA Vaccines & Therapeutics Sales by Application (2020-2031)
3.2.1.1 Global mRNA Vaccines & Therapeutics Sales Volume by Application (2020-2031)
3.2.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2031)
3.2.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
3.2.2.1 Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2031)
3.2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2020-2031)
3.2.3 mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Infectious Disease Vaccines of mRNA Vaccines & Therapeutics Revenue Market Share by Application
3.3.2 Cancer Vaccines of mRNA Vaccines & Therapeutics Revenue Market Share by Application
4 Global mRNA Vaccines & Therapeutics by Manufacturers
4.1 Global Top mRNA Vaccines & Therapeutics Manufacturers by Sales (2020-2025)
4.1.1 Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2020-2025)
4.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top mRNA Vaccines & Therapeutics Manufacturers by Revenue (2020-2025)
4.2.1 Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2020-2025)
4.2.2 Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturer (2020-2025)
4.3 Global mRNA Vaccines & Therapeutics Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key mRNA Vaccines & Therapeutics Manufacturers Covered: Ranking by Revenue
4.4.2 Global mRNA Vaccines & Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Product Type
4.5.1 mRNA Vaccines & Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into mRNA Vaccines & Therapeutics Market
4.5.3 Manufacturers mRNA Vaccines & Therapeutics Product Type and Application
4.5.4 Infectious Disease Vaccines Market Sales of mRNA Vaccines & Therapeutics by Manufacturer
4.5.5 Cancer Vaccines Market Sales of mRNA Vaccines & Therapeutics by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Moderna Therapeutics
5.1.1 Moderna Therapeutics Company Information
5.1.2 Moderna Therapeutics Description, Business Overview
5.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Products Offered
5.1.4 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales by Product in 2024
5.1.6 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales by Application in 2024
5.1.7 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.1.8 Moderna Therapeutics Recent Developments
5.2 CureVac
5.2.1 CureVac Company Information
5.2.2 CureVac Description, Business Overview
5.2.3 CureVac mRNA Vaccines & Therapeutics Products Offered
5.2.4 CureVac mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.2.5 CureVac mRNA Vaccines & Therapeutics Sales by Product in 2024
5.2.6 CureVac mRNA Vaccines & Therapeutics Sales by Application in 2024
5.2.7 CureVac mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.2.8 CureVac Recent Developments
5.3 Translate Bio
5.3.1 Translate Bio Company Information
5.3.2 Translate Bio Description, Business Overview
5.3.3 Translate Bio mRNA Vaccines & Therapeutics Products Offered
5.3.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Translate Bio mRNA Vaccines & Therapeutics Sales by Product in 2024
5.3.6 Translate Bio mRNA Vaccines & Therapeutics Sales by Application in 2024
5.3.7 Translate Bio mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.3.8 Translate Bio Recent Developments
5.4 BioNTech
5.4.1 BioNTech Company Information
5.4.2 BioNTech Description, Business Overview
5.4.3 BioNTech mRNA Vaccines & Therapeutics Products Offered
5.4.4 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.4.5 BioNTech mRNA Vaccines & Therapeutics Sales by Product in 2024
5.4.6 BioNTech mRNA Vaccines & Therapeutics Sales by Application in 2024
5.4.7 BioNTech mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.4.8 BioNTech Recent Developments
5.5 Sangamo Therapeutics
5.5.1 Sangamo Therapeutics Company Information
5.5.2 Sangamo Therapeutics Description, Business Overview
5.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Products Offered
5.5.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales by Product in 2024
5.5.6 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales by Application in 2024
5.5.7 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.5.8 Sangamo Therapeutics Recent Developments
5.6 Argos Therapeutics
5.6.1 Argos Therapeutics Company Information
5.6.2 Argos Therapeutics Description, Business Overview
5.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Products Offered
5.6.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Argos Therapeutics mRNA Vaccines & Therapeutics Sales by Product in 2024
5.6.6 Argos Therapeutics mRNA Vaccines & Therapeutics Sales by Application in 2024
5.6.7 Argos Therapeutics mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.6.8 Argos Therapeutics Recent Developments
5.7 In-Cell-Art
5.7.1 In-Cell-Art Company Information
5.7.2 In-Cell-Art Description, Business Overview
5.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Products Offered
5.7.4 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.7.5 In-Cell-Art mRNA Vaccines & Therapeutics Sales by Product in 2024
5.7.6 In-Cell-Art mRNA Vaccines & Therapeutics Sales by Application in 2024
5.7.7 In-Cell-Art mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.7.8 In-Cell-Art Recent Developments
5.8 eTheRNA
5.8.1 eTheRNA Company Information
5.8.2 eTheRNA Description, Business Overview
5.8.3 eTheRNA mRNA Vaccines & Therapeutics Products Offered
5.8.4 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.8.5 eTheRNA mRNA Vaccines & Therapeutics Sales by Product in 2024
5.8.6 eTheRNA mRNA Vaccines & Therapeutics Sales by Application in 2024
5.8.7 eTheRNA mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.8.8 eTheRNA Recent Developments
5.9 Ethris
5.9.1 Ethris Company Information
5.9.2 Ethris Description, Business Overview
5.9.3 Ethris mRNA Vaccines & Therapeutics Products Offered
5.9.4 Ethris mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Ethris mRNA Vaccines & Therapeutics Sales by Product in 2024
5.9.6 Ethris mRNA Vaccines & Therapeutics Sales by Application in 2024
5.9.7 Ethris mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.9.8 Ethris Recent Developments
5.10 Tiba Biotechnology
5.10.1 Tiba Biotechnology Company Information
5.10.2 Tiba Biotechnology Description, Business Overview
5.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Products Offered
5.10.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales by Product in 2024
5.10.6 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales by Application in 2024
5.10.7 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales by Geographic Area in 2024
5.10.8 Tiba Biotechnology Recent Developments
6 North America
6.1 North America mRNA Vaccines & Therapeutics Market Size YoY Growth 2020-2031
6.2 North America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
6.2.1 North America mRNA Vaccines & Therapeutics Sales by Country (2020-2031)
6.2.2 North America mRNA Vaccines & Therapeutics Revenue by Country (2020-2031)
6.3 North America mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
6.4 North America mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Facts & Figures by Region
7.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2020-2031)
7.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2020-2031)
7.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
7.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
8 Europe
8.1 Europe mRNA Vaccines & Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe mRNA Vaccines & Therapeutics Market Facts & Figures by Country
8.2.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2020-2031)
8.2.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2031)
8.3 Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
8.4 Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
9 Latin America
9.1 Latin America mRNA Vaccines & Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America mRNA Vaccines & Therapeutics Market Facts & Figures by Country
9.2.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2020-2031)
9.2.2 Latin America mRNA Vaccines & Therapeutics Revenue by Country (2020-2031)
9.3 Latin America mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
9.4 Latin America mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America mRNA Vaccines & Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa mRNA Vaccines & Therapeutics Market Facts & Figures by Country
10.2.1 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2020-2031)
10.2.2 Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2031)
10.3 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2020-2025)
10.4 Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 mRNA Vaccines & Therapeutics Supply Chain Analysis
11.2 mRNA Vaccines & Therapeutics Key Raw Materials and Upstream Suppliers
11.3 mRNA Vaccines & Therapeutics Clients Analysis
11.4 mRNA Vaccines & Therapeutics Sales Channel and Sales Model Analysis
11.4.1 mRNA Vaccines & Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 mRNA Vaccines & Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 mRNA Vaccines & Therapeutics Distributors
12 mRNA Vaccines & Therapeutics Market Dynamics
12.1 mRNA Vaccines & Therapeutics Industry Trends
12.2 mRNA Vaccines & Therapeutics Market Drivers
12.3 mRNA Vaccines & Therapeutics Market Challenges
12.4 mRNA Vaccines & Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
List of Tables
 Table 1. Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global mRNA Vaccines & Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global mRNA Vaccines & Therapeutics Sales by Region (2020-2025) & (M Doses)
 Table 5. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2026-2031) & (M Doses)
 Table 6. Global mRNA Vaccines & Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global mRNA Vaccines & Therapeutics Sales Volume by Type (2020-2025) & (M Doses)
 Table 9. Global mRNA Vaccines & Therapeutics Sales Volume by Type (2026-2031) & (M Doses)
 Table 10. Global mRNA Vaccines & Therapeutics Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global mRNA Vaccines & Therapeutics Sales Volume by Application (2020-2025) & (M Doses)
 Table 13. Global mRNA Vaccines & Therapeutics Sales Volume by Application (2026-2031) & (M Doses)
 Table 14. Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global mRNA Vaccines & Therapeutics Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2020-2025) & (M Doses)
 Table 17. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturer (2020-2025)
 Table 18. mRNA Vaccines & Therapeutics Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. mRNA Vaccines & Therapeutics Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers mRNA Vaccines & Therapeutics Price (2020-2025) & (USD/Doses)
 Table 21. Ranking of Global Top mRNA Vaccines & Therapeutics Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global mRNA Vaccines & Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccines & Therapeutics as of 2024)
 Table 24. mRNA Vaccines & Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into mRNA Vaccines & Therapeutics Market
 Table 26. Manufacturers mRNA Vaccines & Therapeutics Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Moderna Therapeutics Company Information
 Table 29. Moderna Therapeutics Description and Business Overview
 Table 30. Moderna Therapeutics mRNA Vaccines & Therapeutics Product
 Table 31. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 32. Moderna Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 33. Moderna Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 34. Moderna Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 35. Moderna Therapeutics Recent Developments
 Table 36. CureVac Company Information
 Table 37. CureVac Description and Business Overview
 Table 38. CureVac mRNA Vaccines & Therapeutics Product
 Table 39. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 40. CureVac Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 41. CureVac Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 42. CureVac Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 43. CureVac Recent Developments
 Table 44. Translate Bio Company Information
 Table 45. Translate Bio Description and Business Overview
 Table 46. Translate Bio mRNA Vaccines & Therapeutics Product
 Table 47. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 48. Translate Bio Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 49. Translate Bio Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 50. Translate Bio Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 51. Translate Bio Recent Developments
 Table 52. BioNTech Company Information
 Table 53. BioNTech Description and Business Overview
 Table 54. BioNTech mRNA Vaccines & Therapeutics Product
 Table 55. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 56. BioNTech Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 57. BioNTech Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 58. BioNTech Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 59. BioNTech Recent Developments
 Table 60. Sangamo Therapeutics Company Information
 Table 61. Sangamo Therapeutics Description and Business Overview
 Table 62. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product
 Table 63. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 64. Sangamo Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 65. Sangamo Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 66. Sangamo Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 67. Sangamo Therapeutics Recent Developments
 Table 68. Argos Therapeutics Company Information
 Table 69. Argos Therapeutics Description and Business Overview
 Table 70. Argos Therapeutics mRNA Vaccines & Therapeutics Product
 Table 71. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 72. Argos Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 73. Argos Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 74. Argos Therapeutics Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 75. Argos Therapeutics Recent Developments
 Table 76. In-Cell-Art Company Information
 Table 77. In-Cell-Art Description and Business Overview
 Table 78. In-Cell-Art mRNA Vaccines & Therapeutics Product
 Table 79. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 80. In-Cell-Art Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 81. In-Cell-Art Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 82. In-Cell-Art Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 83. In-Cell-Art Recent Developments
 Table 84. eTheRNA Company Information
 Table 85. eTheRNA Description and Business Overview
 Table 86. eTheRNA mRNA Vaccines & Therapeutics Product
 Table 87. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 88. eTheRNA Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 89. eTheRNA Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 90. eTheRNA Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 91. eTheRNA Recent Developments
 Table 92. Ethris Company Information
 Table 93. Ethris Description and Business Overview
 Table 94. Ethris mRNA Vaccines & Therapeutics Product
 Table 95. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 96. Ethris Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 97. Ethris Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 98. Ethris Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 99. Ethris Recent Developments
 Table 100. Tiba Biotechnology Company Information
 Table 101. Tiba Biotechnology Description and Business Overview
 Table 102. Tiba Biotechnology mRNA Vaccines & Therapeutics Product
 Table 103. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2020-2025)
 Table 104. Tiba Biotechnology Sales Proportion of mRNA Vaccines & Therapeutics by Product in 2024
 Table 105. Tiba Biotechnology Sales Proportion of mRNA Vaccines & Therapeutics by Application in 2024
 Table 106. Tiba Biotechnology Sales Proportion of mRNA Vaccines & Therapeutics by Geographic Area in 2024
 Table 107. Tiba Biotechnology Recent Developments
 Table 108. North America mRNA Vaccines & Therapeutics Sales by Country (2020-2025) & (M Doses)
 Table 109. North America mRNA Vaccines & Therapeutics Sales by Country (2026-2031) & (M Doses)
 Table 110. North America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 111. North America mRNA Vaccines & Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 112. North America mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
 Table 113. North America mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
 Table 114. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2020-2025) & (M Doses)
 Table 115. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2026-2031) & (M Doses)
 Table 116. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2020-2025) & (US$ Million)
 Table 117. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2026-2031) & (US$ Million)
 Table 118. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
 Table 119. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
 Table 120. Europe mRNA Vaccines & Therapeutics Sales by Country (2020-2025) & (M Doses)
 Table 121. Europe mRNA Vaccines & Therapeutics Sales by Country (2026-2031) & (M Doses)
 Table 122. Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 123. Europe mRNA Vaccines & Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 124. Europe mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
 Table 125. Europe mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
 Table 126. Latin America mRNA Vaccines & Therapeutics Sales by Country (2020-2025) & (M Doses)
 Table 127. Latin America mRNA Vaccines & Therapeutics Sales by Country (2026-2031) & (M Doses)
 Table 128. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 129. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 130. Latin America mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
 Table 131. Latin America mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
 Table 132. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2020-2025) & (M Doses)
 Table 133. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2026-2031) & (M Doses)
 Table 134. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) & (US$ Million)
 Table 135. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2026-2031) & (US$ Million)
 Table 136. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Type (2020-2025) & (M Doses)
 Table 137. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Application (2020-2025) & (M Doses)
 Table 138. mRNA Vaccines & Therapeutics Key Raw Materials, Industry Status and Trend
 Table 139. mRNA Vaccines & Therapeutics Key Raw Materials and Upstream Suppliers
 Table 140. mRNA Vaccines & Therapeutics Clients Status and Trend
 Table 141. mRNA Vaccines & Therapeutics Typical Clients
 Table 142. mRNA Vaccines & Therapeutics Distributors
 Table 143. mRNA Vaccines & Therapeutics Market Trends
 Table 144. mRNA Vaccines & Therapeutics Market Drivers
 Table 145. mRNA Vaccines & Therapeutics Market Challenges
 Table 146. mRNA Vaccines & Therapeutics Market Restraints
 Table 147. Research Programs/Design for This Report
 Table 148. Key Data Information from Secondary Sources
 Table 149. Key Data Information from Primary Sources
 Table 150. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. mRNA Vaccines & Therapeutics Product Picture
 Figure 2. Global mRNA Vaccines & Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2024 & 2031
 Figure 4. Infectious Disease Vaccines Product Picture
 Figure 5. Cancer Vaccines Product Picture
 Figure 6. Global mRNA Vaccines & Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Application in 2024 & 2031
 Figure 8. Infectious Disease
 Figure 9. Cancer
 Figure 10. mRNA Vaccines & Therapeutics Report Years Considered
 Figure 11. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global mRNA Vaccines & Therapeutics Market Size 2020-2031 (US$ Million)
 Figure 13. Global mRNA Vaccines & Therapeutics Sales 2020-2031 (M Doses)
 Figure 14. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 16. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Type (2020-2025) & (USD/Doses)
 Figure 19. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. mRNA Vaccines & Therapeutics Average Selling Price (ASP) by Application (2020-2025) & (USD/Doses)
 Figure 22. Infectious Disease Vaccines of mRNA Vaccines & Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Cancer Vaccines of mRNA Vaccines & Therapeutics Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global mRNA Vaccines & Therapeutics Sales Share by Manufacturer in 2024
 Figure 25. mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Infectious Disease Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 27. Cancer Vaccines Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America mRNA Vaccines & Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 29. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
 Figure 30. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific mRNA Vaccines & Therapeutics Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
 Figure 36. Europe mRNA Vaccines & Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2031)
 Figure 38. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 39. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
 Figure 40. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
 Figure 41. Latin America mRNA Vaccines & Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2031)
 Figure 43. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
 Figure 45. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)
 Figure 51. mRNA Vaccines & Therapeutics Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of mRNA Vaccines & Therapeutics Raw Materials by Region in 2024
 Figure 53. mRNA Vaccines & Therapeutics Distribution Channels
 Figure 54. Global mRNA Vaccines & Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global mRNA Vaccines & Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030
Global mRNA Cancer Vaccines and Therapeutics Market Insights Forecast to 2030
Global RNA Vaccines Market Insights Forecast to 2030
Global mRNA Therapy Market Research Report 2024
mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Synthesis Manufacturing Market Research Report 2024
Global mRNA Treatment Market Research Report 2024
Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Vaccines and mRNA Drugs Market Research Report 2024
Global mRNA Development and Manufacturing Services Market Research Report 2025
Global mRNA Vaccine Raw Materials Market Research Report 2024
Global Livestock mRNA Vaccines Market Research Report 2025
Global mRNA Delivery System Market Research Report 2024
Global Veterinary mRNA Vaccines Market Research Report 2025
Global mRNA Vaccine Core Enzyme Market Research Report 2025
Global mRNA Vaccine Drugs Development Services Market Research Report 2024
mRNA Sequencing
mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global mRNA Flu Vaccine Market Research Report 2024

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions